All articles by GlobalData Healthcare

  1. Axonics Modulation Technologies emerges as a major player in sacral neuromodulation

    On 9 September, Axonics Modulation Technologies announced it had received approval by the US Food and Drug Administration (FDA) to…
    Read More…

    24 Sep
  2. Is telemedicine the future for Alzheimer’s care?

    In the last of a series of three articles for World Alzheimer’s Day (21 September), we consider future treatments for…
    Read More…

    24 Sep
  3. First long-distance PCI procedure in India opens an opportunity for untapped patient pool

    In September 2019, a cardiologist in India performed the first percutaneous coronary intervention (PCI) procedure using Corindus Vascular Robotocis’ CorPathGRX…
    Read More…

    23 Sep
  4. Exact Sciences to acquire Genomic Health in cancer diagnostics space

    Exact Sciences has now entered into a definite $2.8bn agreement to acquire Genomic Health. Exact Sciences is the manufacturer of…
    Read More…

    23 Sep
  5. Axial Spondyloarthritis market due to see mild growth

    Despite the development of treatments with novel mechanisms of action (MOAs), the axial spondyloarthritis (axSpA) market is anticipated to experience…
    Read More…

    2 Sep
  6. Success for AstraZeneca’s heart failure therapy Farxiga

    Earlier this month, AstraZeneca announced the success of its heart failure (HF) treatment Farxiga, branded as Forxiga in the EU. HF…
    Read More…

    2 Sep
  7. Market growth in prostate cancer largely attributed to label expansions

    The four second-generation hormonal therapies have been racing to acquire approvals and label expansions over the past couple of years. These…
    Read More…

    2 Sep
  8. Are drug-sparing regimens the next step in HIV management?

    Reductions in pill burden and dosing, improvements in safety and tolerability, and increased barriers to resistance have changed HIV management….
    Read More…

    2 Sep
  9. First neuromodulation device for heart failure gains FDA approval

    Minnesota-based CVRx has won FDA approval for the first neuromodulation device designed for the treatment of heart failure and high…
    Read More…

    30 Aug
  10. TAVI procedure volume poised to spike

    According to GlobalData estimates, in recent years, Transcatheter aortic valve implantation (TAVI) has exploded as an extremely successful intervention, with…
    Read More…

    29 Aug
Close
Close
Close

Go Top